Csaba P. Kovesdy

TL;DR: A review of the current evidence on the gut-targeted interventions to control uremia, fluid overload, hyperkalemia and hyperphosphatemia in patients with chronic kidney disease is presented in this article.

TL;DR: Differences in outcomes are likely among veterans with diabetes based on race and geography despite adherence to therapy, and localized analyses may uncover specific social determinants contributing to differences in outcomes.

TL;DR: The World Kidney Day as mentioned in this paper promotes education on the harmful consequences of obesity and its association with kidney disease, advocating healthy lifestyle and health policy measures that makes preventive behaviors an affordable option.

TL;DR: In this paper , the authors describe real-world patiromer utilization in an ESKD population and its corresponding association with serum K+ level changes, and show that patients with end stage kidney disease are more likely to discontinue their first treatment within 30 days, while approximately 10% of patients remained persistent at the end of the 180-day period and 102 (22.3%) patients started a second treatment episode after a 30-day gap in treatment during the 180day follow up period.

TL;DR: Patiromer utilization and associated changes in serum potassium (K+) in US veterans with prior sodium polystyrene sulfonate exposure was evaluated in a real-world observational study as mentioned in this paper .